HeartSine Quality Expert Appointed Chairperson of RQA Medical Devices Committee

Colette McIntyre, HeartSine’s Good Laboratory Practice/Good Clinical Practice Specialist, has been appointed Chairperson of the Medical Devices Committee of the Research Quality Association (RQA) within just a year of being appointed to the committee.

In her new role, McIntyre will continue to focus on supporting RQA’s objectives, as well as developing additional training materials to help professionals in the medical device industry better understand regulatory requirements. The committee also will be contributing to the 2015 RQA Annual Conference by planning several lectures and hosting a Q&A clinic, granting attendees the opportunity to have their questions regarding medical device regulations answered. McIntyre first joined the RQA Medical Devices Committee in early 2014.

The RQA, an association for professionals working in research in pharmaceuticals, agrochemicals, chemicals and medical devices, drives quality and integrity in scientific research and development by developing and promoting quality standards in scientific research and development, facilitating knowledge sharing and transfer, and liaising with regulatory agencies in the development and interpretation of regulations and guidance.

The Medical Devices Committee of the RQA seeks to support the association’s strategy, to provide a forum for discussion and clarification of medical device issues, to assist the association to play an active role in any consultative process related to medical device matters, and to promote effective liaison and provide informed opinion to regulatory bodies on medical device matters.

In her role within HeartSine’s Clinical department, McIntyre ensures when conducting pre-clinical or clinical studies, the company complies with the requirements of the Good Laboratory Practice and Good Clinical Practice regulations.

“Colette is an extremely astute, valued member of HeartSine’s clinical team, ensuring strict compliance to all relevant standards at every stage of clinical and pre-clinical studies,” says Rebecca DiMaio, Ph.D., HeartSine’s Clinical Research Manager. “Her extensive quality management system and auditing expertise are vital in delivering continuous quality improvement within HeartSine.”